StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
599
This month
2
This week
2
This year
171
Today
1
Yesterday
1
Publishing Date
2023 - 10 - 31
3
2023 - 10 - 17
3
2023 - 09 - 26
3
2023 - 09 - 22
4
2023 - 06 - 08
3
2023 - 05 - 30
3
2023 - 05 - 01
3
2023 - 04 - 05
3
2023 - 02 - 02
3
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 07 - 30
3
2021 - 07 - 09
3
2021 - 06 - 25
3
2021 - 06 - 17
3
2021 - 06 - 10
5
2021 - 06 - 09
2
2021 - 06 - 04
3
2021 - 06 - 02
2
2021 - 05 - 25
2
2021 - 05 - 24
3
2021 - 05 - 21
2
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 14
3
2021 - 04 - 13
3
2021 - 04 - 12
2
2021 - 04 - 07
3
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 16
2
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Sector
Commercial services
1
Communications
3
Consumer non-durables
1
Consumer services
1
Distribution services
1
Electronic technology
2
Energy minerals
3
Finance
10
Finance and insurance
1
Health services
5
Health technology
598
Information
2
Manufacturing
50
N/a
19
Process industries
10
Producer manufacturing
2
Professional, scientific, and technical services
3
Retail trade
4
Technology services
5
Tags
Agreement
7
Alliances
20
Antibody
13
Application
20
Approval
47
Biotech-bay
13
Cancer
102
Car-t
8
Cell
16
Cell carcinoma
11
Chmp
16
Clinical-trials-phase-ii
15
Clinical-trials-phase-iii
18
Collaboration
31
Conference
17
Disease
20
Drug
61
Earnings
21
Europe
16
Events
22
Expected
8
Fda
17
Financial
16
Financial results
17
Food
23
Genetown
8
Global
59
Growing
13
Growth
32
Immunotherapy
16
Int230
9
Iot
11
License
12
Lung
13
Market
106
Meeting
8
N/a
295
Nivolumab
58
Opdivo
31
People
13
Pharm-country
57
Pharmaceutical
11
Pharmaceuticals
8
Phase 1
10
Phase 2
15
Phase 3
12
Positive
26
Product-news
14
Psoriasis
8
Renal
11
Report
60
Research
73
Results
58
Solid tumors
10
T-cell
8
Therapeutics
40
Therapy
60
Treatment
82
Trial
45
Update
8
Entities
2seventy bio, inc.
8
Abbott laboratories
24
Abbvie inc.
74
Adc therapeutics sa
13
Advaxis, inc.
8
Agenus inc.
5
Agios pharmaceuticals, inc.
12
Albemarle corporation
8
Alexion pharmaceuticals, inc.
16
Alnylam pharmaceuticals, inc.
10
Amgen inc.
73
Astellas pharma inc
6
Astrazeneca plc
53
Aveo pharmaceuticals, inc.
19
Ayala pharmaceuticals, inc.
12
Bausch health companies inc.
9
Beigene, ltd.
11
Biocryst pharmaceuticals, inc.
13
Biogen inc.
9
Biomarin pharmaceutical inc.
5
Bluebird bio, inc.
8
Blueprint medicines corporation
19
Bolt biotherapeutics inc
7
Boston scientific corporation
5
Bristol-myers squibb company
598
Clovis oncology, inc.
20
Eli lilly and company
95
Epizyme, inc.
18
Evotec se
5
Evotec se - adr
5
Exelixis, inc.
29
Gilead sciences, inc.
40
Glaxosmithkline plc
60
Illumina, inc.
10
Incyte corporation
23
Intensity therapeutics, inc.
12
Johnson & johnson
79
Karyopharm therapeutics inc.
19
Medtronic plc
6
Mirati therapeutics, inc.
8
Mylan n.v.
12
Nektar therapeutics
7
Neos therapeutics, inc.
13
Novartis ag
88
Omeros corporation
13
Otonomy, inc.
13
Pfizer, inc.
60
Regeneron pharmaceuticals, inc.
29
Replimune group, inc.
6
Rigel pharmaceuticals, inc.
11
Sanofi
106
Takeda pharmaceutical company limited
39
Teva pharmaceutical industries limited
8
Teva pharmaceutical industries ltd
28
Turning point therapeutics, inc.
7
Ucb s.a.
6
Verastem, inc.
11
Viatris inc.
14
Xeris pharmaceuticals, inc.
10
Y-mabs therapeutics, inc.
18
Symbols
AAPL
1097
ABB
1306
ABBV
918
ABLZF
1046
ABT
1556
AMGN
698
ARVL
3820
AZN
589
BDX
724
BMY
599
BNPQF
1635
BNPQY
1635
BNPZY
1634
CNY
2031
CSCO
815
DHR
726
ERIC
1467
EXTR
581
F
569
FNCTF
6134
GE
852
GLAXF
609
GOOG
1109
GOOGL
1109
GSK
829
HON
1621
HUBS
1306
IBM
606
INR
2034
INTC
882
JNJ
3999
LLY
1555
LTUM
876
LYV
718
MDT
1197
MLPY
2032
MMM
874
MS
3657
MS-PE
1460
MSFT
1128
NOK
825
NOKBF
887
NVS
1113
NVSEF
906
ORCL
1083
PCRFF
592
PCRFY
592
PFE
645
PHG
887
PPRUF
1007
PPRUY
1008
SAP
1399
SAPGF
1133
SNOW
709
SNY
4012
SNYNF
3067
TMO
1434
TOT
1597
URR
2030
VZ
1065
Exchanges
Amex
2
Lse
23
Nasdaq
357
Nyse
598
Tsx
4
Crawled Date
2023 - 09 - 26
3
2023 - 09 - 22
4
2023 - 09 - 18
3
2023 - 06 - 08
3
2023 - 06 - 01
3
2023 - 05 - 30
3
2023 - 05 - 01
3
2023 - 04 - 05
3
2023 - 02 - 02
3
2023 - 01 - 27
3
2022 - 08 - 10
3
2022 - 06 - 06
3
2022 - 06 - 03
3
2022 - 06 - 02
3
2022 - 04 - 12
4
2022 - 04 - 05
3
2022 - 02 - 25
3
2021 - 11 - 12
3
2021 - 11 - 03
3
2021 - 10 - 01
3
2021 - 09 - 17
3
2021 - 09 - 16
3
2021 - 09 - 08
3
2021 - 08 - 19
3
2021 - 07 - 30
3
2021 - 07 - 27
3
2021 - 07 - 09
3
2021 - 06 - 25
3
2021 - 06 - 10
5
2021 - 06 - 09
2
2021 - 06 - 04
3
2021 - 06 - 02
2
2021 - 05 - 25
4
2021 - 05 - 21
2
2021 - 05 - 20
5
2021 - 05 - 19
3
2021 - 05 - 18
4
2021 - 05 - 13
2
2021 - 05 - 12
3
2021 - 05 - 05
2
2021 - 04 - 29
3
2021 - 04 - 28
4
2021 - 04 - 23
5
2021 - 04 - 22
2
2021 - 04 - 16
4
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
4
2021 - 04 - 07
3
2021 - 03 - 29
2
2021 - 03 - 25
2
2021 - 03 - 19
3
2021 - 03 - 16
2
2021 - 03 - 11
2
2021 - 03 - 04
2
2021 - 01 - 20
2
2021 - 01 - 11
2
2021 - 01 - 04
2
2020 - 12 - 11
3
2020 - 12 - 08
2
Crawled Time
00:00
16
00:01
1
01:00
8
02:00
6
03:00
2
04:00
2
04:20
2
05:00
1
06:00
3
07:00
4
08:00
5
08:20
1
09:00
4
10:00
8
10:41
1
10:43
1
10:51
2
10:57
1
11:00
22
11:36
1
12:00
101
12:01
1
12:02
1
12:04
1
12:15
15
12:20
17
12:24
1
12:30
9
12:34
1
13:00
64
13:07
1
13:13
1
13:15
4
13:17
1
13:20
10
13:27
1
13:30
3
13:50
1
14:00
34
14:03
1
14:15
1
14:20
7
14:30
5
14:58
1
15:00
27
15:01
1
15:15
2
15:20
4
16:00
29
16:20
3
17:00
23
18:00
19
18:04
2
18:26
2
18:31
2
19:00
15
20:00
20
21:00
25
22:00
20
23:00
13
Source
feed.businesswire.com
2
mindmed.co
1
savarapharma.com
1
www.biospace.com
303
www.fda.gov
46
www.globenewswire.com
44
www.prnewswire.com
202
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Bmy
save search
Bristol Myers Squibb Announces Phase 3 CheckMate -8HW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab)
Published:
2023-12-07
(Crawled : 18:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
0.0%
|
O:
1.06%
H:
0.0%
C:
0.0%
opdivo
trial
plus
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Opdivo (nivolumab)
Published:
2023-12-05
(Crawled : 16:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
Email alert
Add to watchlist
drug
opdivo
review
food
application
Avidity Biosciences Announces Expansion of Cardiovascular Collaboration with Bristol Myers Squibb for up to Five Targets Utilizing Avidity's Proprietary AOC™ Platform Technology
Published:
2023-11-28
(Crawled : 20:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
1.55%
|
O:
0.06%
H:
0.55%
C:
-0.27%
RNA
|
$8.04
1.39%
1.37%
850K
|
Health Technology
|
25.32%
|
O:
25.32%
H:
3.63%
C:
-8.29%
expansion
collaboration
technology
cardiovascular
platform
Locally Advanced Pancreatic Cancer Market Report 2023-2028: Recent Advancements in Immunotherapy Inject New Hope into LAPC Market
Published:
2023-11-21
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
$125.75
8.15%
2.6K
|
Health Technology
|
1.87%
|
O:
0.36%
H:
0.0%
C:
-0.05%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
2.68%
|
O:
0.56%
H:
1.53%
C:
1.37%
AZN
|
News
|
$63.5
-0.14%
-0.14%
6.2M
|
Health Technology
|
0.34%
|
O:
-0.89%
H:
0.33%
C:
-0.16%
report
hope
cancer
pancreatic
immunotherapy
market
Bristol Myers Squibb and 2seventy bio Provide Update on U.S. FDA Review of sBLA for Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma
Published:
2023-11-20
(Crawled : 13:00)
- biospace.com/
TSVT
|
$2.65
12.77%
11.32%
2.1M
|
|
-0.46%
|
O:
-12.96%
H:
1.06%
C:
-7.45%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-2.74%
|
O:
-4.69%
H:
2.85%
C:
0.25%
fda
review
update
therapy
FDA Roundup: November 17, 2023
Published:
2023-11-17
(Crawled : 22:00)
- prnewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
Email alert
Add to watchlist
fda
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
News
|
$155.4
-0.78%
-0.02%
6.4M
|
Health Technology
|
6.03%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-2.08%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
4.82%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
$78.03
-1.68%
-1.7%
8.2M
|
Health Technology
|
5.3%
|
O:
-0.13%
H:
0.0%
C:
0.0%
reach
research
hiv
market
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-6.88%
|
O:
-4.83%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$155.4
-0.78%
-0.02%
6.4M
|
Health Technology
|
5.67%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-5.13%
|
O:
-3.68%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
5.0%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
News
|
$63.5
-0.14%
-0.14%
6.2M
|
Health Technology
|
-1.02%
|
O:
-2.88%
H:
0.0%
C:
0.0%
report
research
market
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
Published:
2023-11-10
(Crawled : 12:30)
- prnewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-5.13%
|
O:
-3.68%
H:
0.0%
C:
0.0%
MRTX
|
$56.64
-0.02%
-0.02%
2.3M
|
Health Technology
|
0.87%
|
O:
-0.11%
H:
0.0%
C:
0.0%
krasg12
lung
chmp
positive
cancer
cell
treatment
therapeutics
Tempus Announces Research Collaboration with Bristol Myers Squibb to Apply Multimodal AI Approaches
Published:
2023-11-08
(Crawled : 20:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-5.81%
|
O:
-0.62%
H:
0.11%
C:
-0.19%
research
collaboration
HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORS
Published:
2023-11-08
(Crawled : 13:00)
- prnewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-5.81%
|
O:
-0.62%
H:
0.11%
C:
-0.19%
STIM
|
$1.8
-4.76%
-5.0%
55K
|
Health Technology
|
42.34%
|
O:
5.11%
H:
0.0%
C:
0.0%
HRMY
|
$31.07
-3.09%
-3.19%
780K
|
Health Technology
|
29.29%
|
O:
-2.78%
H:
0.59%
C:
-1.72%
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-06
(Crawled : 15:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-3.36%
|
O:
3.16%
H:
0.77%
C:
-0.66%
MRTX
|
$56.64
-0.02%
-0.02%
2.3M
|
Health Technology
|
1.83%
|
O:
0.75%
H:
0.59%
C:
0.27%
therapeutics
financial
results
Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors
Published:
2023-11-06
(Crawled : 13:00)
- globenewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-3.36%
|
O:
3.16%
H:
0.77%
C:
-0.66%
al102
drug
tumors
pharmaceuticals
designation
Kura Oncology and Mirati Therapeutics Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASᴳ¹²ᶜ-Mutated NSCLC
Published:
2023-11-02
(Crawled : 12:00)
- globenewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-3.84%
|
O:
-1.84%
H:
1.08%
C:
0.61%
MRTX
|
$56.64
-0.02%
-0.02%
2.3M
|
Health Technology
|
1.65%
|
O:
0.2%
H:
0.43%
C:
-0.38%
KURA
|
$11.27
1.81%
1.77%
800K
|
Health Technology
|
28.57%
|
O:
-4.76%
H:
6.0%
C:
5.25%
ko-2806
collaboration
therapeutics
agreement
Bristol Myers Squibb Appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, Effective April 1, 2024
Published:
2023-10-31
(Crawled : 00:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-3.73%
|
O:
-0.65%
H:
0.0%
C:
0.0%
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published:
2023-10-31
(Crawled : 11:00)
- prnewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-3.73%
|
O:
-0.65%
H:
0.0%
C:
0.0%
XNCR
|
$20.2
4.88%
4.65%
500K
|
Health Technology
|
7.75%
|
O:
-0.46%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.06
0.17%
0.17%
1.9M
|
Health Technology
|
4.21%
|
O:
2.61%
H:
0.0%
C:
0.0%
REGN
|
$849.57
1.65%
1.63%
560K
|
Health Technology
|
5.33%
|
O:
-0.51%
H:
0.0%
C:
0.0%
BGNE
J
|
$182.01
-1.16%
-1.18%
180K
|
Health Technology
|
0.93%
|
O:
1.38%
H:
0.0%
C:
0.0%
AMGN
S
|
$271.33
0.74%
0.73%
2M
|
Health Technology
|
2.32%
|
O:
-3.22%
H:
0.0%
C:
0.0%
financial
results
Bristol Myers Squibb Prices $4.5 Billion of Senior Unsecured Notes
Published:
2023-10-31
(Crawled : 06:00)
- biospace.com/
MS
|
News
0 d
|
$80.35
1.18%
-0.03%
5.3M
|
Finance
|
14.72%
|
O:
0.83%
H:
0.0%
C:
0.0%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-3.73%
|
O:
-0.65%
H:
0.0%
C:
0.0%
MRTX
|
$56.64
-0.02%
-0.02%
2.3M
|
Health Technology
|
2.33%
|
O:
0.46%
H:
0.0%
C:
0.0%
Karyopharm Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Novel CELMoD™ Agent CC- 92480 Mezigdomide in Combination with Selinexor in Patients with Relapsed/Refractory Multiple Myeloma
Published:
2023-10-30
(Crawled : 13:00)
- biospace.com/
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-2.43%
|
O:
1.35%
H:
0.0%
C:
0.0%
KPTI
|
News
|
$0.8353
-1.83%
-1.87%
750K
|
Health Technology
|
0.38%
|
O:
2.92%
H:
6.08%
C:
-3.35%
collaboration
trial
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
Published:
2023-10-26
(Crawled : 13:00)
- biospace.com/
XYF
2 d
|
$3.76
1.62%
2.39%
18K
|
Finance
|
1.08%
|
O:
2.29%
H:
4.87%
C:
4.87%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-12.07%
|
O:
-4.68%
H:
2.46%
C:
-1.83%
MRTX
|
$56.64
-0.02%
-0.02%
2.3M
|
Health Technology
|
2.74%
|
O:
0.16%
H:
0.47%
C:
0.2%
financial
results
Global HIV Diagnostics Market Predicted to Reach $1.5 Billion by 2030, with a CAGR of 5.5%
Published:
2023-10-25
(Crawled : 18:00)
- prnewswire.com
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-11.44%
|
O:
-0.34%
H:
1.34%
C:
1.05%
GILD
|
$78.03
-1.68%
-1.7%
8.2M
|
Health Technology
|
1.11%
|
O:
-0.31%
H:
0.89%
C:
0.62%
reach
global
hiv
diagnostics
market
← Previous
1
2
3
4
5
6
7
8
9
…
29
30
Next →
Gainers vs Losers
69%
31%
Top 10 Gainers
SLDB
M
|
$5.89
72.22%
41.94%
12M
|
Health Technology
SVFD
|
$3.09
43.72%
30.42%
64M
|
FTEL
|
$2.04
43.66%
30.39%
110K
|
HPCO
4
|
$0.4824
41.92%
29.54%
28M
|
ALGS
|
$0.6475
-5.06%
26.67%
2.1M
|
Health Technology
GTHX
|
$3.16
30.58%
23.42%
10M
|
Health Technology
KEQU
|
News
|
$22.5
27.62%
21.64%
24K
|
Producer Manufacturing
GSIT
|
$3.09
27.16%
21.36%
2.2M
|
Electronic Technology
SSKN
P
|
$0.628
25.6%
20.38%
210K
|
Health Technology
GLUE
|
$3.66
22.82%
18.58%
510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.